The synthesis of cannabidiol has been accomplished by several research groups.

It can be synthesized by Birch reduction from the nonyl-analog of cannabidiol.

The Czechs in 1997 still published farm crop reports on strategies to grow cannabidiol rich hemp.

It is a ring-opened cannabinoid derivative, an analogue of cannabidiol.

Cannabidiol was significantly more protective than either vitamin E or vitamin C.

Cannabidiol is a Schedule 2 Drug in Canada.

Next, a cannabinoid is simply a class of closely related substances such as Tetrahydrocannabinol and Cannabidiol.

Cannabidiol is an allosteric modulator of μ and δ-opioid receptors.

Sativex contains tetrahydrocannabinol together with cannabidiol and is a preparation of whole cannabis rather than individual cannabinoids.

Like cannabidiol, cannabigerol is not psychoactive.

Some research suggests that the antipsychotic effects of cannabidiol potentially represent a novel mechanism in the treatment of schizophrenia.

Cannabidiol is insoluble in water but soluble in organic solvents, such as pentane.

Cannabidiol Cannabidiol has been found to be effective in reducing symptoms of dystonia.

HU-331 a potential anti-cancer drug derived from cannabidiol that specifically inhibits topoisomerase II.

THC and cannabidiol are also neuroprotective antioxidants.

The most important cannabinoid in industrial hemp is cannabidiol (CBD) with a proportion of 1 to 5%.

Isolated and identified cannabidiol from Cannabis sativa, showed its relationship to cannabinol and tetrahydrocannabinol .

However, unlike cannabidiol, this compound produces potent cannabis-like effects in animals, suggesting it acts as a CB agonist.

HU-331 is a quinone anticarcinogenic drug synthesized from cannabidiol, a cannabinoid in the Cannabis sativa plant.

Cannabidiol is showing promise in inhibiting the psychosis-like effects of THC, and indicating great therapeutic potential.

Cannabis plants not only contain THC (tetrahydrocannabinol) but also two other related compounds, tetrahydrocannabivarin and cannabidiol.

Sativex contains an equal ratio of two cannabinoids: tetrahydrocannabinol, which is psychoactive, and cannabidiol, which is not.

The plant-biosynthesized cannabinoid cannabidiol also shows "either direct or indirect activation" of TRPV1 receptors.

Sativex, a fixed dose combination of delta-9-tetrahydrocannabinol (THC) and cannabidiol, is sold as an oromucosal spray.

Studies have shown cannabidiol decreases activity of the limbic system and decreases social isolation induced by THC.